Showing 531-540 of 19230 results for "".
A New Health Plan to Eliminate Diabetes Patients’ Out-of-Pocket Costs
https://reachmd.com/programs/the-drug-report/a-new-health-plan-to-eliminate-diabetes-patients-out-of-pocket-costs/11286/CVS Health recently announced a new plan to eliminate out-of-pocket costs associated with diabetes prescription medicines. Here are the details.No Patient with CKD Left Behind! Emerging CKD Therapies in T1D
https://reachmd.com/programs/cme/no-patient-with-ckd-left-behind-emerging-ckd-therapies-in-t1d/36524/Gain insights in CKD screening practices, pathophysiology, and treatment from the results of the FINE-1 trial evaluating finerenone in patients with type 1 diabetes.How Low Carb Diets Enhance Gestational Diabetes Control
https://reachmd.com/programs/nutritionedge/how-low-carb-diets-enhance-gestational-diabetes-control/7674/Controlling blood sugar and weight gain in expectant patients with gestational diabetes can be challenging. But the move toward lower carbohydrate diets for these patients has shown promise in controlling diabetic progression through pregnancy. Joining host Kathy King to discuss the mechanisms and rEvolocumab in Patients Without Significant Atherosclerosis and With Diabetes: A Cardiology Perspective on VESALIUS-CV
https://reachmd.com/clinical-practice/cardiology/evolocumab-in-patients-without-significant-atherosclerosis-and-with-diabetes-a-cardiology-perspective-on-vesalius-cv/56744/New VESALIUS-CV data show broad cardiovascular benefits of evolocumab in high-risk primary prevention patients with diabetes and no atherosclerosis.Managing Erectile Dysfunction Stemming from Diabetes and Heart Disease
https://reachmd.com/programs/clinicians-roundtable/managing-erectile-dysfunction-stemming-from-diabetes-heart-disease/8035/Dr. Charles Walker discusses erectile dysfunction as a common complication for patients dealing with diabetes and heart disease, and how to manage it.Semaglutide Reduces CV Events in Non-Diabetic, Overweight Patients
https://reachmd.com/programs/diabetes-discourse/semaglutide-reduces-cv-events-in-non-diabetic-overweight-patients/18109/Tune in to find out how semaglutide affects cardiovascular outcomes in patients who are overweight or obese, but do not have diabetes.Advances in Continuous Glucose Monitoring
https://reachmd.com/programs/diabetes-discourse/advances-in-continuous-glucose-monitoring/5341/Continuous glucose monitoring is an effective tool in the management of both type 1 diabetes and insulin-requiring type 2 diabetes patients. However, barriers and challenges remain for both the healthcare provider and patient. Join host Dr. Steven Edelman and his guest, director of the Advanced MetaPolitical Solutions for the Diabetes Pandemic
https://reachmd.com/programs/clinicians-roundtable/political-solutions-for-the-diabetes-pandemic/1782/Dr. Maurice Pickard discusses with Dr. Nigel Unwin the need for governments to create an environment that allows individuals to make lifestyle changes. The adoption of western culture's poor dietary habits and reduced exercise lifestyles, as well as expanding urban environments fostering these shifWhat Do Young Doctors Know About Diabetes Management?
https://reachmd.com/programs/diabetes-discourse/what-do-young-doctors-know-about-diabetes-management/6463/A new study suggests newly trained physicians may not be adequately prepared to treat patients with diabetes. Host Dr. Steven Edelman, talks with Dr. Stephen Ponder, pediatric endocrinologist at Texas A&M, with 27 years of professional experience in the management of children with diabetes, abKey Considerations for CGM Use in Older Adults with T1D
https://reachmd.com/programs/diabetes-discourse/key-considerations-for-cgm-use-in-older-adults-with-t1d/15156/Get the latest insights on how continuous glucose monitoring can affect older adults with type 1 diabetes.